Nav: Home

Genetic mutation causes ataxia in humans and dogs

June 16, 2016

Cerebellar ataxia is a condition of the cerebellum that causes an inability to coordinate muscle movements. A study publishing June 16 in Cell Reports now describes a new genetic mutation as an additional cause of ataxia in humans and mice. The mutation, in the gene CAPN1, affects the function of the enzyme calpain-1 and causes abnormal brain development. The same genetic mutation is also associated with ataxia in Parson Russell Terrier dogs.

"There are a number of genes linked to motor function that can be involved in ataxia when mutated," says Michel Baudry, a neurobiologist at Western University of Health Sciences. "Not only have we identified another, but we've also refined our understanding of the calpain enzymes, which is important because several companies have been talking about using calpain inhibitors to treat neurodegenerative diseases."

Calpain is an enzyme involved with learning, memory, and neurodegeneration in the brain, but it comes in two major forms--calpain-1 and calpain-2. "Nobody could make much progress on figuring out what each form of calpain was doing, because most of the pharmacological studies used molecules that inhibit both types at once" says Baudry. But about eight years ago, Baudry's team obtained a line of mice genetically engineered to lack only calpain-1 to examine the differences.

Baudry's mouse studies caught the attention of Henry Houlden, a neurologist at University College London, who was leading a team investigating ataxia. "Around two years ago, we identified two families with CAPN1 mutations with ataxia and spasticity," Houlden explains. Once the researchers determined that the mutation affected calpain-1's function, they looked up Baudry's work on the calpain-1 knockout mice. "Together, we started to investigate the function of this gene," says Houlden. The current study includes four families with members that have CAPN1 mutations and display symptoms of ataxia.

Baudry's team started testing whether the knockout mice had ataxia by tracking their balance when placed on a rotating rod. "We had never looked at the cerebellum in our mice before," says Baudry. "But sure enough, we found that they had mild cerebellar ataxia."

The researchers demonstrated that during the first week after birth, the mice lacking calpain-1 had a much higher rate of neuronal death in their cerebellum, as compared to normal mice, and many of their synapses failed to mature.

"Calpain-1 is neuroprotective," explains Baudry. "When the brain matures, excess neurons are supposed to be pruned--but calpain-1 prevents that process from getting out of control." The team further determined that calpain-1 works normally by degrading an enzyme called PHLPP1, a protein phosphatase involved in programmed cell death. Injecting another compound involved in the pathway during the first postnatal week caused the newborn mice with CAPN1 mutations to develop normally.

Pharmacologically, the attempts to use calpain inhibitors in the clinic may not be working because they don't discriminate between calpain-1 and calpain-2, says Baudry: "If you want to try to address neurodegeneration, you have to use a calpain-2 inhibitor." Baudry is currently working with a team to develop calpain-2 inhibitors as neuroprotective drugs, under the umbrella of a new company called NeurAegis.
-end-
This study was supported by NINDS, the Agence Nationale de la Recherche, the Verum Foundation, the patient association "Connaitre les Syndromes cérébelleux," the Roger de Spoelberg Foundation, and the European Union.

Cell Reports, Wang et al.: "Defects in the CAPN1 gene result in alterations in cerebellar development and in cerebellar ataxia in mice and humans" http://www.cell.com/cell-reports/fulltext/S2211-1247(16)30627-1

Cell Reports (@CellReports), published by Cell Press, is a weekly open-access journal that publishes high-quality papers across the entire life sciences spectrum. The journal features reports, articles, and resources that provide new biological insights, are thought-provoking, and/or are examples of cutting-edge research. Visit: http://www.cell.com/cell-reports. To receive Cell Press media alerts, contact press@cell.com.

Cell Press

Related Brain Articles:

Scientists predict the areas of the brain to stimulate transitions between different brain states
Using a computer model of the brain, Gustavo Deco, director of the Center for Brain and Cognition, and Josephine Cruzat, a member of his team, together with a group of international collaborators, have developed an innovative method published in Proceedings of the National Academy of Sciences on Sept.
BRAIN Initiative tool may transform how scientists study brain structure and function
Researchers have developed a high-tech support system that can keep a large mammalian brain from rapidly decomposing in the hours after death, enabling study of certain molecular and cellular functions.
Wiring diagram of the brain provides a clearer picture of brain scan data
In a study published today in the journal BRAIN, neuroscientists led by Michael D.
Blue Brain Project releases first-ever digital 3D brain cell atlas
The Blue Brain Cell Atlas is like ''going from hand-drawn maps to Google Earth'' -- providing previously unavailable information on major cell types, numbers and positions in all 737 brain regions.
Landmark study reveals no benefit to costly and risky brain cooling after brain injury
A landmark study, led by Monash University researchers, has definitively found that the practice of cooling the body and brain in patients who have recently received a severe traumatic brain injury, has no impact on the patient's long-term outcome.
Brain cells called astrocytes have unexpected role in brain 'plasticity'
Researchers from the Salk Institute have shown that astrocytes -- long-overlooked supportive cells in the brain -- help to enable the brain's plasticity, a new role for astrocytes that was not previously known.
Largest brain study of 62,454 scans identifies drivers of brain aging
In the largest known brain imaging study, scientists from Amen Clinics (Costa Mesa, CA), Google, John's Hopkins University, University of California, Los Angeles and the University of California, San Francisco evaluated 62,454 brain SPECT (single photon emission computed tomography) scans of more than 30,000 individuals from 9 months old to 105 years of age to investigate factors that accelerate brain aging.
Is whole-brain radiation still best for brain metastases from small-cell lung cancer?
University of Colorado Cancer Center study compares outcomes of 5,752 small-cell lung cancer patients who received whole-brain radiation therapy (WBRT) with those of 200 patients who received stereotactic radiosurgery (SRS), finding that the median overall survival was actually longer with SRS (10.8 months with SRS versus 7.1 months with WBRT).
Atlas of brain blood vessels provides fresh clues to brain diseases
Even though diseases of the brain vasculature are some of the most common causes of death in the West, knowledge of these blood vessels is limited.
Brain sciences researcher pinpoints brain circuit that triggers fear relapse
Steve Maren, the Claude H. Everett Jr. '47 Chair of Liberal Arts professor in the Department of Psychological and Brain Sciences at Texas A&M University, and his Emotion and Memory Systems Laboratory (EMSL) have made a breakthrough discovery in the process of fear relapse.
More Brain News and Brain Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#538 Nobels and Astrophysics
This week we start with this year's physics Nobel Prize awarded to Jim Peebles, Michel Mayor, and Didier Queloz and finish with a discussion of the Nobel Prizes as a way to award and highlight important science. Are they still relevant? When science breakthroughs are built on the backs of hundreds -- and sometimes thousands -- of people's hard work, how do you pick just three to highlight? Join host Rachelle Saunders and astrophysicist, author, and science communicator Ethan Siegel for their chat about astrophysics and Nobel Prizes.